<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01309906</url>
  </required_header>
  <id_info>
    <org_study_id>688E</org_study_id>
    <nct_id>NCT01309906</nct_id>
  </id_info>
  <brief_title>Evaluation of the Feasibility a New Silicone Hydrogel Contact Lens</brief_title>
  <official_title>A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the clinical feasibility and to evaluate the&#xD;
      product performance of an investigational contact lens.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>At 1 week follow up</time_frame>
    <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Eyes With &gt; Grade 2 Slit Lamp Findings</measure>
    <time_frame>At 1 week follow up</time_frame>
    <description>Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). The outcome measure is any finding &gt; grade 2, across abnormalities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms and Complaints</measure>
    <time_frame>At 1 week follow up</time_frame>
    <description>At 1-Week Follow-up, subjects were asked to rate 16 common symptoms/complaints on a scale of 0 to 100, with 100 being the most favorable score.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Investigational lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bausch &amp; Lomb investigational silicone hydrogel lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air Optix Aqua lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ciba Vision Air Optix Aqua contact lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational lens</intervention_name>
    <description>Bausch &amp; Lomb investigational silicone hydrogel contact lens worn on a daily wear basis for 1 week.</description>
    <arm_group_label>Investigational lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Air Optix Aqua lens</intervention_name>
    <description>Ciba Visions Air Optix Aqua contact lens, worn on a daily wear basis for 1 week.</description>
    <arm_group_label>Air Optix Aqua lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have physiologically normal anterior segments not exhibiting clinically significant&#xD;
             biomicroscopy findings.&#xD;
&#xD;
          -  Be myopic and require lens correction in each eye.&#xD;
&#xD;
          -  Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must&#xD;
             be of the same manufacture and brand.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any systemic disease affecting ocular health.&#xD;
&#xD;
          -  Using any systemic or topical medications that will affect ocular physiology or lens&#xD;
             performance.&#xD;
&#xD;
          -  An active ocular disease, any corneal infiltrative response or are using any ocular&#xD;
             medications.&#xD;
&#xD;
          -  Any &quot;Present&quot; finding during the slit lamp examination that, in the Investigator's&#xD;
             judgment, interferes with contact lens wear.&#xD;
&#xD;
          -  Allergic to any component in the study care products.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tara Vaz, OD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bausch &amp; Lomb Incorporated</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 4, 2011</study_first_submitted>
  <study_first_submitted_qc>March 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2011</study_first_posted>
  <results_first_submitted>August 21, 2020</results_first_submitted>
  <results_first_submitted_qc>September 29, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 22, 2020</results_first_posted>
  <last_update_submitted>September 29, 2020</last_update_submitted>
  <last_update_submitted_qc>September 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 66 participants (132 eyes) were enrolled in the study. One-half were randomized to receive the investigational lens, and the other half were randomized to receive the control lens. After one week of wearing the first lens type, the subjects returned for an exam and crossed over to the second lens type for one week.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Investigational Lens Then Air Optix Aqua Lens</title>
          <description>Bausch &amp; Lomb investigational silicone hydrogel lens&#xD;
Investigational lens: Bausch &amp; Lomb investigational silicone hydrogel contact lens worn on a daily wear basis for 1 week.&#xD;
Ciba Vision Air Optix Aqua contact lens Air Optix Aqua lens: Ciba Visions Air Optix Aqua contact lens, worn on a daily wear basis for 1 week.</description>
        </group>
        <group group_id="P2">
          <title>Air Optix Aqua Lens Then Investigational Lens</title>
          <description>Ciba Vision Air Optix Aqua contact lens&#xD;
Air Optix Aqua lens: Ciba Visions Air Optix Aqua contact lens, worn on a daily wear basis for 1 week.&#xD;
Bausch &amp; Lomb investigational silicone hydrogel lens Investigational lens: Bausch &amp; Lomb investigational silicone hydrogel contact lens worn on a daily wear basis for 1 week.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall</title>
          <description>All participants received both treatment groups.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="66"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.1" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
        <time_frame>At 1 week follow up</time_frame>
        <population>There were 65 subjects (130 eyes) in each group for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Lens</title>
            <description>Bausch &amp; Lomb investigational silicone hydrogel lens&#xD;
Investigational lens: Bausch &amp; Lomb investigational silicone hydrogel contact lens worn on a daily wear basis for 1 week.</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua Lens</title>
            <description>Ciba Vision Air Optix Aqua contact lens&#xD;
Air Optix Aqua lens: Ciba Visions Air Optix Aqua contact lens, worn on a daily wear basis for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity</title>
          <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
          <population>There were 65 subjects (130 eyes) in each group for this outcome measure.</population>
          <units>logMAR</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="130"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.038" spread="0.088"/>
                    <measurement group_id="O2" value="-0.040" spread="0.088"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Eyes With &gt; Grade 2 Slit Lamp Findings</title>
        <description>Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). The outcome measure is any finding &gt; grade 2, across abnormalities.</description>
        <time_frame>At 1 week follow up</time_frame>
        <population>There were 65 subjects (130 eyes) in each group for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Lens</title>
            <description>Bausch &amp; Lomb investigational silicone hydrogel lens&#xD;
Investigational lens: Bausch &amp; Lomb investigational silicone hydrogel contact lens worn on a daily wear basis for 1 week.</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua Lens</title>
            <description>Ciba Vision Air Optix Aqua contact lens&#xD;
Air Optix Aqua lens: Ciba Visions Air Optix Aqua contact lens, worn on a daily wear basis for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Eyes With &gt; Grade 2 Slit Lamp Findings</title>
          <description>Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). The outcome measure is any finding &gt; grade 2, across abnormalities.</description>
          <population>There were 65 subjects (130 eyes) in each group for this outcome measure.</population>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="130"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Symptoms and Complaints</title>
        <description>At 1-Week Follow-up, subjects were asked to rate 16 common symptoms/complaints on a scale of 0 to 100, with 100 being the most favorable score.</description>
        <time_frame>At 1 week follow up</time_frame>
        <population>There were 65 subjects (130 eyes) in each group for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Lens</title>
            <description>Bausch &amp; Lomb investigational silicone hydrogel lens&#xD;
Investigational lens: Bausch &amp; Lomb investigational silicone hydrogel contact lens worn on a daily wear basis for 1 week.</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua Lens</title>
            <description>Ciba Vision Air Optix Aqua contact lens&#xD;
Air Optix Aqua lens: Ciba Visions Air Optix Aqua contact lens, worn on a daily wear basis for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Symptoms and Complaints</title>
          <description>At 1-Week Follow-up, subjects were asked to rate 16 common symptoms/complaints on a scale of 0 to 100, with 100 being the most favorable score.</description>
          <population>There were 65 subjects (130 eyes) in each group for this outcome measure.</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="130"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Burning/stinging upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.7" spread="16.7"/>
                    <measurement group_id="O2" value="90.5" spread="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.6" spread="18.9"/>
                    <measurement group_id="O2" value="86.9" spread="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.7" spread="18.4"/>
                    <measurement group_id="O2" value="87.8" spread="18.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort at end of day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.1" spread="22.7"/>
                    <measurement group_id="O2" value="79.2" spread="22.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.3" spread="17.8"/>
                    <measurement group_id="O2" value="91.7" spread="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.7" spread="13.0"/>
                    <measurement group_id="O2" value="93.2" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dryness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.0" spread="19.8"/>
                    <measurement group_id="O2" value="81.8" spread="19.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itchiness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.2" spread="16.2"/>
                    <measurement group_id="O2" value="90.4" spread="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" spread="11.3"/>
                    <measurement group_id="O2" value="93.1" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.1" spread="14.8"/>
                    <measurement group_id="O2" value="92.7" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.3" spread="14.8"/>
                    <measurement group_id="O2" value="90.7" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision in low light</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.9" spread="14.9"/>
                    <measurement group_id="O2" value="88.6" spread="14.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens cleanness upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.6" spread="12.2"/>
                    <measurement group_id="O2" value="93.4" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens cleanness upon removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.4" spread="17.6"/>
                    <measurement group_id="O2" value="89.5" spread="17.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall impression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.9" spread="19.4"/>
                    <measurement group_id="O2" value="84.5" spread="19.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens cleanness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.9" spread="17.0"/>
                    <measurement group_id="O2" value="89.6" spread="17.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 weeks</time_frame>
      <desc>Adverse events were not coded. Therefore source vocabulary is not applicable.</desc>
      <group_list>
        <group group_id="E1">
          <title>Investigational Lens</title>
          <description>Bausch &amp; Lomb investigational silicone hydrogel lens&#xD;
Investigational lens: Bausch &amp; Lomb investigational silicone hydrogel contact lens worn on a daily wear basis for 1 week.</description>
        </group>
        <group group_id="E2">
          <title>Air Optix Aqua Lens</title>
          <description>Ciba Vision Air Optix Aqua contact lens&#xD;
Air Optix Aqua lens: Ciba Visions Air Optix Aqua contact lens, worn on a daily wear basis for 1 week.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Contact sponsor directly for details.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Bausch Health</organization>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

